Corporate insider
Rangwala Reshma
EVP & Chief Medical OfficerCIK 0001825322
Disclosed transactions1
Buys / sells0 / 1
Max Insider Score21
Connections with evidence1
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Rangwala ReshmaEVP & Chief Medical Officer |  KPTIKaryopharm Therapeutics Inc.Open-market sale | SELL | $4,014 449 sh | Apr 22, 2026 traded Apr 21, 2026 |
Verified connections
- Insider ofevidenceKaryopharm Therapeutics Inc.EVP & Chief Medical Officer · Apr 22, 2026